Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-31 08:15 |
Nomination Committee appointed in respect of AGM 2025 in Alligator Bioscience AB
|
English | 61.8 KB | ||
| 2024-10-31 08:15 |
Valberedning utsedd inför årsstämma 2025 i Alligator Bioscience AB
|
Swedish | 61.4 KB | ||
| 2024-10-24 08:00 | Swedish | 2.9 MB | |||
| 2024-10-24 08:00 | English | 2.9 MB | |||
| 2024-07-11 08:00 | Swedish | 2.9 MB | |||
| 2024-07-11 08:00 | English | 2.9 MB | |||
| 2024-06-26 08:00 |
Alligator Bioscience meddelar omfattande överlevnadsfördelar och en oöverträffa…
|
Swedish | 83.9 KB | ||
| 2024-06-26 08:00 |
Alligator Bioscience Announces Substantial Overall Survival Benefit and Unprece…
|
English | 83.3 KB | ||
| 2024-06-25 20:30 |
Alligator Bioscience announces financing of up to SEK 80 million extending cash…
|
English | 80.3 KB | ||
| 2024-06-25 20:30 |
Alligator Bioscience offentliggör finansiering om upp till 80 MSEK som förlänge…
|
Swedish | 81.1 KB | ||
| 2024-06-14 12:30 |
Alligator Bioscience Apppoints Johan Giléus as Chief Financial Officer
|
English | 64.7 KB | ||
| 2024-06-14 12:30 |
Alligator Bioscience utser Johan Giléus till Chief Financial Officer
|
Swedish | 67.9 KB | ||
| 2024-05-07 16:15 |
Bulletin from the annual general meeting in Alligator Bioscience AB on 7 May 20…
|
English | 69.8 KB | ||
| 2024-05-07 16:15 |
Kommuniké från årsstämma den 7 maj 2024 i Alligator Bioscience AB
|
Swedish | 69.4 KB | ||
| 2024-05-06 08:00 | Swedish | 3.0 MB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
